About StratiCELL
StratiCELL is a company based in Gembloux (Belgium) founded in 2005 was acquired by Plant Advanced Technologies in January 2016. The company has 11 employees as of December 31, 2022. StratiCELL offers products and services including Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform. StratiCELL operates in a competitive market with competitors including Evelo Biosciences, PathogenDX, Omass, Phylos Bioscience and AFYREN, among others.
- Headquarter Gembloux, Belgium
- Employees 11 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Straticell
-
Annual Revenue
Not available
-
Net Profit
$45.75 K (USD)-80as on Dec 31, 2022
-
EBITDA
$370.62 K (USD)413as on Dec 31, 2021
-
Latest Funding Round
$440.38 K (USD), Grant
Oct 01, 2020
-
Investors
Plant Advanced Technologies
& 1 more
-
Employee Count
11
as on Dec 31, 2022
-
Acquired by
Plant Advanced Technologies
(Jan 07, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of StratiCELL
StratiCELL offers a comprehensive portfolio of products and services, including Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform.
In vitro testing for cosmetic claims and ingredient efficacy
Screening for drug effects on skin biology and conditions
Platform for testing impacts on skin microbiome and infections
Funding Insights of StratiCELL
Investors in StratiCELL
StratiCELL has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Plant Advanced Technologies and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Plant biotechnology is applied to cosmetic and pharmaceutical uses.
|
Locked | Locked | Locked |
Investor details for StratiCELL
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by StratiCELL
Investment portfolio details for StratiCELL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - StratiCELL
Detailed financials for StratiCELL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Straticell Comparisons
Peer comparison for StratiCELL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of StratiCELL
StratiCELL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, PathogenDX, Omass, Phylos Bioscience and AFYREN, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| Locked | Locked | Locked |
Provider of DNA-based pathogen testing kits
|
|
| Locked | Locked | Locked |
Native mass spectrometry services for protein characterization are provided.
|
|
| Locked | Locked | Locked |
Developer of cannabis breeding tools for agriculture & other health purposes
|
|
| Locked | Locked | Locked |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| Locked | Locked | Locked |
Service provider in analytical testing
|
Detailed competitors of StratiCELL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Straticell
Complete news archive for StratiCELL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StratiCELL
StratiCELL was founded in 2005 and raised its 1st funding round 15 years after it was founded.
StratiCELL is headquartered in Gembloux, Belgium. It is registered at Gembloux, Namur, Belgium.
As of Dec 31, 2022, the latest employee count at StratiCELL is 11.
StratiCell was founded in 2005 in Gembloux, Belgium, where in vitro testing services for dermatological actives and products are conducted following topical or systemic applications. Testing is performed on monolayer cell cultures, reconstituted human epithelia, and human skin biopsies within the biotechnology sector. The company was acquired in January 2016 by Plant Advanced Technologies for an undisclosed amount.
StratiCELL's top competitors include PathogenDX, AFYREN and Perfectus Biomed.
StratiCELL offers Cosmetic Testing, Dermatology Testing, and MicroBIOS Platform.
StratiCELL has 2 investors. Key investors include Plant Advanced Technologies, and European Union.